Healthcare provider profile · identity verified

Daniel W Belcher, MD

Internal Medicine · INDIANAPOLIS, IN · NPI 1447216932

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	364	101
Amlodipine Besylate	Amlodipine Besylate	346	96
Levothyroxine Sodium	Levothyroxine Sodium	240	61
Lisinopril	Lisinopril	234	67
Hydrochlorothiazide	Hydrochlorothiazide	223	65
Gabapentin	Gabapentin	220	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	210	37
Omeprazole	Omeprazole	197	53
Losartan Potassium	Losartan Potassium	191	61
Trazodone Hcl	Trazodone Hcl	179	50
Metformin Hcl	Metformin Hcl	125	34
Pantoprazole Sodium	Pantoprazole Sodium	119	29
Albuterol Sulfate Hfa	Albuterol Sulfate	111	40
Meloxicam	Meloxicam	110	25
Tramadol Hcl	Tramadol Hcl	99	23
Simvastatin	Simvastatin	96	26
Metoprolol Succinate	Metoprolol Succinate	93	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	93	12
Fluticasone Propionate	Fluticasone Propionate	90	25
Ozempic	Semaglutide	84	13
Sertraline Hcl	Sertraline Hcl	82	23
Metformin Hcl Er	Metformin Hcl	80	26
Tamsulosin Hcl	Tamsulosin Hcl	78	25
Allopurinol	Allopurinol	73	19
Pravastatin Sodium	Pravastatin Sodium	73	21
Metoprolol Tartrate	Metoprolol Tartrate	70	20
Fluoxetine Hcl	Fluoxetine Hcl	62	19
Naproxen	Naproxen	60	16
Alendronate Sodium	Alendronate Sodium	57	14
Furosemide	Furosemide	57	16
Lovastatin	Lovastatin	56	16
Prednisone	Prednisone	55	30
Duloxetine Hcl	Duloxetine Hcl	53	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	12
Potassium Chloride	Potassium Chloride	49	12
Glimepiride	Glimepiride	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	11
Pregabalin	Pregabalin	47	16
Mounjaro	Tirzepatide	46	suppressed
Montelukast Sodium	Montelukast Sodium	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Finasteride	Finasteride	42	suppressed
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Eliquis	Apixaban	40	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	suppressed
Trulicity	Dulaglutide	39	suppressed
Diazepam	Diazepam	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	12
Bupropion Xl	Bupropion Hcl	34	11
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	12
Warfarin Sodium	Warfarin Sodium	30	suppressed
Atenolol	Atenolol	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Promethazine Hcl	Promethazine Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	14
Propranolol Hcl	Propranolol Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Colchicine	Colchicine	25	suppressed
Fluconazole	Fluconazole	25	13
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	12
Famotidine	Famotidine	24	12
Valsartan	Valsartan	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Testosterone	Testosterone	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Azithromycin	Azithromycin	19	17
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Cephalexin	Cephalexin	18	16
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Primidone	Primidone	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	16	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Amoxicillin	Amoxicillin	15	14
Jardiance	Empagliflozin	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Ec-Naproxen	Naproxen	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Alprazolam Er	Alprazolam	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Methylprednisolone	Methylprednisolone	12	12
Rosuvastatin Calcium	Rosuvastatin Calcium	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Glipizide	Glipizide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error